Low-Dose Valacyclovir for Cytomegalovirus Infection Prophylaxis After a Heart Transplant.

CONCLUSIONS: In this study, we hypothesized that daily use of low-dose valacyclovir (1000 mg/d) is not only sufficient for cytomegalovirus prophylaxis but also beneficial in terms of cost. PMID: 26976362 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/26976362?dopt=Abstract

Source: Experimental and Clinical Transplantation : official journal of the Middle East Society for Organ Transplantation - March 14, 2016 Category: Transplant Surgery Authors: Kervan U, Kucuker SA, Kocabeyoglu SS, Unal EU, Ozatik MA, Sert DE, Kavasoglu K, Tezer AY, Pac M Tags: Exp Clin Transplant Source Type: research